357 related articles for article (PubMed ID: 16207186)
1. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
3. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
[TBL] [Abstract][Full Text] [Related]
4. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
[TBL] [Abstract][Full Text] [Related]
5. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
Mulekar SV; Al Issa A; Al Eisa A
Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
[TBL] [Abstract][Full Text] [Related]
6. Melanocyte-keratinocyte cell transplantation for stable vitiligo.
Mulekar SV
Int J Dermatol; 2003 Feb; 42(2):132-6. PubMed ID: 12709002
[TBL] [Abstract][Full Text] [Related]
7. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
8. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
[TBL] [Abstract][Full Text] [Related]
10. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
Gupta S; Goel A; Kanwar AJ; Kumar B
Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
[TBL] [Abstract][Full Text] [Related]
11. Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study.
Mulekar SV; Ghwish B; Al Issa A; Al Eisa A
Br J Dermatol; 2008 Jan; 158(1):45-9. PubMed ID: 17927795
[TBL] [Abstract][Full Text] [Related]
12. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
Issa CM; Rehder J; Taube MB
Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
[TBL] [Abstract][Full Text] [Related]
13. Treatment of vitiligo with a melanocyte-keratinocyte cell suspension versus dermabrasion only: a pilot study with a 12-month follow up.
Vázquez-Martínez OT; Martínez-Rodríguez HG; Velásquez-Arenas L; Baños-González D; Ortíz-López R; Padilla-Rivas G; Welsh O; Ocampo-Candiani J
J Drugs Dermatol; 2011 Sep; 10(9):1032-6. PubMed ID: 22052273
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP
Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
[TBL] [Abstract][Full Text] [Related]
15. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
[TBL] [Abstract][Full Text] [Related]
16. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
Sahni K; Parsad D; Kanwar AJ
Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
[TBL] [Abstract][Full Text] [Related]
17. Noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo.
Mohanty S; Kumar A; Dhawan J; Sreenivas V; Gupta S
Br J Dermatol; 2011 Jun; 164(6):1241-6. PubMed ID: 21275943
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo.
Tegta GR; Parsad D; Majumdar S; Kumar B
Int J Dermatol; 2006 Feb; 45(2):106-10. PubMed ID: 16445497
[TBL] [Abstract][Full Text] [Related]
19. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts.
Kahn AM; Cohen MJ
Dermatol Surg; 1998 Mar; 24(3):365-7. PubMed ID: 9537012
[TBL] [Abstract][Full Text] [Related]
20. Tissue-engineered skin in the treatment of vitiligo lesions.
Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
